1. Home
  2. AURA vs ATOM Comparison

AURA vs ATOM Comparison

Compare AURA & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • ATOM
  • Stock Information
  • Founded
  • AURA 2007
  • ATOM 2001
  • Country
  • AURA United States
  • ATOM United States
  • Employees
  • AURA N/A
  • ATOM N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • ATOM Semiconductors
  • Sector
  • AURA Health Care
  • ATOM Technology
  • Exchange
  • AURA Nasdaq
  • ATOM Nasdaq
  • Market Cap
  • AURA 379.6M
  • ATOM 333.8M
  • IPO Year
  • AURA 2021
  • ATOM 2016
  • Fundamental
  • Price
  • AURA $7.77
  • ATOM $8.64
  • Analyst Decision
  • AURA Strong Buy
  • ATOM Strong Buy
  • Analyst Count
  • AURA 4
  • ATOM 1
  • Target Price
  • AURA $23.00
  • ATOM $7.00
  • AVG Volume (30 Days)
  • AURA 162.1K
  • ATOM 1.3M
  • Earning Date
  • AURA 11-12-2024
  • ATOM 02-11-2025
  • Dividend Yield
  • AURA N/A
  • ATOM N/A
  • EPS Growth
  • AURA N/A
  • ATOM N/A
  • EPS
  • AURA N/A
  • ATOM N/A
  • Revenue
  • AURA N/A
  • ATOM $662,000.00
  • Revenue This Year
  • AURA N/A
  • ATOM N/A
  • Revenue Next Year
  • AURA N/A
  • ATOM $2,800.00
  • P/E Ratio
  • AURA N/A
  • ATOM N/A
  • Revenue Growth
  • AURA N/A
  • ATOM 13140.00
  • 52 Week Low
  • AURA $6.63
  • ATOM $2.31
  • 52 Week High
  • AURA $12.38
  • ATOM $17.55
  • Technical
  • Relative Strength Index (RSI)
  • AURA 39.85
  • ATOM 44.63
  • Support Level
  • AURA $7.46
  • ATOM $8.30
  • Resistance Level
  • AURA $7.90
  • ATOM $11.90
  • Average True Range (ATR)
  • AURA 0.30
  • ATOM 2.14
  • MACD
  • AURA -0.00
  • ATOM -0.75
  • Stochastic Oscillator
  • AURA 34.65
  • ATOM 3.68

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the most widely used transistor type in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, FinFET technology, logic and processors, and SRAM.

Share on Social Networks: